The singe-use upstream bioprocessing technology market is projected to grow at a CAGR of 12% till 2035, claims Roots Analysis

0 0

Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems Given the various benefits of single-use technology and the rising demand for biologics, the biopharmaceutical industry is gradually shifting from conventional manufacturing equipment to single-use upstream bioprocessing systems

 68 total views,  2 views today

Leave A Reply

Your email address will not be published.